Liver Metastases of Pancreatic Cancer
- 1 November 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 40 (8) , 1271-1275
Abstract
Objective: To evaluate the effect of chemoembolization on pancreatic cancer liver metastases. Method: Thirty-two patients with pancreatic cancer liver metastases retrospectively underwent chemoembolization (4- to 8-week intervals). Size-based evaluation (response evaluation criteria in solid tumors [RECIST]) and survival indexes were assessed overall and for sex and number of lesions. Results: Of the patients, 71.87% showed stable disease, 9.37% partial response (PR) and 18.75% progressive disease (PD). Survival rate for 1, 3, and 5 years from first TACE was 60%, 25%, and 11%, respectively. Median survival time was 16 months and for stable disease group was 20 months. Progression-free survival for 6 months and 1, 3, and 5 years was 84%, 57.3%, 20%, and 10%, respectively. There was significant difference between men and women in response. Survival rates for 1 and 5 years for the men were 80% and 14% and for the women were 47% and 0%. There was no significant difference between oligonodular liver lesion (n < 5) and multinodular (n > 5) groups. Survival rates for 1 and 5 years for oligonodular were 84% and 14%, and for multinodular was 50% and 0%. Conclusion: Repetitive TACE resulted in a relevant response for the control of liver metastases of pancreatic cancer with respectable median survival time. Interestingly, the number of lesions, statistically, was not an effective factor.Keywords
This publication has 20 references indexed in Scilit:
- Racial/Ethnic Patterns of Care for Pancreatic CancerJournal of Palliative Medicine, 2009
- Pancreatic Cancer: A Review of the Evidence on CausationClinical Gastroenterology and Hepatology, 2008
- Transarterielle Chemoperfusion mit Gemcitabine und Mitomycin C bei Pankreaskarzinom: Ergebnisse bei Rezidivtumoren und fortgeschrittenen TumorstadienRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2007
- A new approach to managing intraductal papillary mucinous pancreatic neoplasmsGut, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative TherapyAnnals of Surgical Oncology, 2006
- Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response CriteriaJapanese Journal of Clinical Oncology, 2003
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Catheter Replacement of the Needle in Percutaneous Arteriography: A new techniqueActa Radiologica, 1953